PHOENIX, March 13, 2020 /PRNewswire/ — eVisit, the enterprise virtual care platform that simplifies healthcare delivery, today announced its offering VirtualED—a preconfigured workflow of its platform that’s specific to coronavirus—to hospitals free of charge through July 31, 2020. This configuration of the eVisit platform enables hospitals to screen for COVID-19, triage patients to the appropriate care setting, and treat COVID-19 and non-emergency patients virtually, keeping staff and patients safe while reducing the potential spread of the virus. VirtualED includes quick deployment, so hospitals can be up and running in as little as two weeks at no cost.
Increased access to telehealth services during this public health emergency is crucial to managing the outbreak. The Centers for Disease Control and Prevention (CDC) recommends that healthcare organizations use telehealth tools to address COVID-19 preparedness and direct patients to the right level of care to meet their medical needs. In addition, Medicare, Medicaid, and commercial payors are taking steps to reduce telehealth reimbursement barriers to encourage more widespread telehealth usage.
“These reimbursement initiatives are crucial to increasing access to telehealth during this growing pandemic,” said Bret Larsen, chief executive officer at eVisit. “With eVisit’s VirtualED, hospitals can easily treat patients with suspected or confirmed cases of COVID-19 at their home, keeping them out of clinical settings. In addition, VirtualEd enables hospitals to conduct initial COVID-19 screening virtually. We want to do our part to keep hospital staff and patients safe while slowing the spread of the virus.”
How It Works
“We created the eVisit virtual care platform to be highly configurable so it can adapt to a situation just like this,” said Miles Romney, chief technology officer at eVisit. “We’ve pre-configured our virtual care platform for emergency department triage specific to COVID-19 so hospitals can be up and running before a possible peak of COVID-19 cases in April or May. Together, we can keep staff and patients safe—and COVID-19 out of hospital EDs—while slowing the spread of the virus.”
As part of this offering, hospitals get eVisit’s VirtualED software subscription for free through July 31, 2020, quick-start deployment, preconfigured ED triage workflow, COVID-19 intake screening form based on the latest CDC recommendations, eVisit web and mobile applications, and unlimited patient usage. To learn more about eVisit VirtualED available to hospitals at no cost, call 1-844-693-8474 or email info@evisit.com.
About eVisit
eVisit simplifies healthcare delivery with its market leading virtual care platform. With eVisit, healthcare organizations can deliver faster, more accessible virtual care using their own network of providers, regardless of specialty. eVisit works seamlessly across enterprise service lines and departments to improve outcomes, reduce costs, and boost revenue. Based in Mesa, Arizona, eVisit helps more than 200 healthcare organizations, including the largest systems in the United States, innovate and succeed in today’s changing healthcare market. For more information, visit evisit.com.
Media Contact
Elise Pelletier
epelletier@lambert.com
C:989-670-5480
O: 616-258-5778
View original content to download multimedia:http://www.prnewswire.com/news-releases/evisit-commits-telehealth-expertise-technology-to-fight-against-covid-19-301023078.html
SOURCE eVisit
MEMPHIS, Tenn., July 5, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare announced its four Memphis-based adult hospitals…
TEMPE, Ariz., July 5, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in June…
mCare Digital unveils the mCareWatch MW-241 powered by KORE connectivity ATLANTA, July 5, 2024 /PRNewswire/…
Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of…
Image acquisition and defocusing correction techniques enable observations of atomic-scale magnetic fields at never-before-seen resolution…
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical…